Cite
APA Citation
Rosner, S., Sen, F., & Postow, M. (2017). response after treatment with pembrolizumab in a patient with myelophthisis due to melanoma: the role of checkpoint inhibition in the bone. Journal for immunotherapy of cancer, 5(1), . http://access.bl.uk/ark:/81055/vdc_100144253069.0x000014